MDS Virtual Congress 2020 Archives - Page 64 of 149

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation via Extracellular Vesicle Dysregulation

K. Jewett, R. Thomas, C. Phan, G. Milstein, S. Yu, L. Pallanck, M. Davis (Seattle, WA, USA)
Goalkeeper Game: a new assessment tool for prediction of gait performance under complex condition in people with Parkinson’s disease

R. Stern, M. d'Alencar, Y. Uscapi, M. Gubitoso, A. Roque, A. Helene, M. Piemonte (São Carlos, Brazil)
Gpi Deep Brain Stimulation After Many Years of Subthalamic Nucleus Stimulation: Case Report

Z. Tufekcioglu, T. Karanci, S. Albayrak (Istanbul, Turkey)
GPNMB protein levels in CNS are modulated by PD risk variant rs199347

Y. Seo, M. Diaz Ortiz, D. Weintraub, V. Van Deerlin, J. Trojanowski, A. Chen-Plotkin (Philadelphia, PA, USA)
Graph theory analysis of dopamine D2 receptor network in Parkinson’s disease patients

A. Mihaescu, J. Kim, S. Cho, M. Diez-Cirarda, M. Valli, Y. Koshimori, A. Strafella (Toronto, ON, Canada)
Gut Microbiota in Parkinson’s disease: influences of device-assisted therapies

M. Lubomski, X. Xu, A. Holmes, J. Yang, R. Davis, C. Sue (Sydney, Australia)
Gut Microbiote Distinctive Features and Microbiota-Metabolome Profile in Parkinson’s Disease: Focus on Levodopa and LCIG

M. Melis, V. Oppo, S. Vascellari, M. Fabbri, M. Sarchioto, D. Murgia, M. Zibetti, L. Lopiano, A. Manzin, G. Cossu (Cagliari, Italy)
GWAS on impulse control disorders in Parkinson’s disease

S. Bekadar, F.X Lejeune, F. Danjou, M. Vidailhet, M. Anheim, A. Elbaz, G. Alves, O.B Tysnes, A.H Erga, J. Maple-Grodem, A. Brice, J.C Corvol (Paris, France)
H1/H2 MAPT Haplotype and Parkinson’s Disease in an Ashkenazi Jewish Cohort

G. Yahalom, L. Greenbaum, S. Israeli-Korn, T. Fay-Karmon, V. Livneh, S. Hassin-Baer, Z. Gan-Or, J. Ruskey, E. Leveille, U. Rudakou, L. Krohn, G. Rouleau (Jerusalem, Israel)
Hand Fine Motor Performance Capacity is Associated with the Cognition in People with Moderate to Advanced Parkinson’s disease

S. Tan, C.T Hong, T.H Liou (New Taipei City, Taiwan)